KYMR
Price
$39.05
Change
-$0.01 (-0.03%)
Updated
Dec 19, 12:37 PM (EDT)
63 days until earnings call
SVRA
Price
$3.19
Change
+$0.17 (+5.63%)
Updated
Dec 19, 10:31 AM (EDT)
84 days until earnings call
Ad is loading...

KYMR vs SVRA

Header iconKYMR vs SVRA Comparison
Open Charts KYMR vs SVRABanner chart's image
Kymera Therapeutics
Price$39.05
Change-$0.01 (-0.03%)
Volume$100
CapitalizationN/A
Savara
Price$3.19
Change+$0.17 (+5.63%)
Volume$100
CapitalizationN/A
KYMR vs SVRA Comparison Chart
Loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KYMR vs. SVRA commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Hold and SVRA is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (KYMR: $39.06 vs. SVRA: $3.02)
Brand notoriety: KYMR and SVRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 127% vs. SVRA: 44%
Market capitalization -- KYMR: $2.74B vs. SVRA: $519.15M
KYMR [@Biotechnology] is valued at $2.74B. SVRA’s [@Biotechnology] market capitalization is $519.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $482.1B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileSVRA’s FA Score has 0 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • SVRA’s FA Score: 0 green, 5 red.
According to our system of comparison, KYMR is a better buy in the long-term than SVRA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 4 TA indicator(s) are bullish while SVRA’s TA Score has 4 bullish TA indicator(s).

  • KYMR’s TA Score: 4 bullish, 6 bearish.
  • SVRA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, SVRA is a better buy in the short-term than KYMR.

Price Growth

KYMR (@Biotechnology) experienced а -13.23% price change this week, while SVRA (@Biotechnology) price change was -13.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.87%. For the same industry, the average monthly price growth was -2.00%, and the average quarterly price growth was +1.19%.

Reported Earning Dates

KYMR is expected to report earnings on Feb 20, 2025.

SVRA is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Biotechnology (-3.87% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($2.74B) has a higher market cap than SVRA($519M). KYMR YTD gains are higher at: 53.417 vs. SVRA (-35.745). SVRA has higher annual earnings (EBITDA): -88.58M vs. KYMR (-160.96M). KYMR has more cash in the bank: 550M vs. SVRA (219M). SVRA has less debt than KYMR: SVRA (26.7M) vs KYMR (88.2M). KYMR has higher revenues than SVRA: KYMR (87.6M) vs SVRA (0).
KYMRSVRAKYMR / SVRA
Capitalization2.74B519M528%
EBITDA-160.96M-88.58M182%
Gain YTD53.417-35.745-149%
P/E RatioN/AN/A-
Revenue87.6M0-
Total Cash550M219M251%
Total Debt88.2M26.7M330%
FUNDAMENTALS RATINGS
SVRA: Fundamental Ratings
SVRA
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
54
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KYMRSVRA
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 25 days ago
85%
Bullish Trend 14 days ago
81%
Declines
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
85%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
N/A
View a ticker or compare two or three
Ad is loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MDVSX9.73N/A
N/A
MassMutual Diversified Value R5
FPPVX11.61-0.13
-1.11%
MFS Prudent Investor R6
FSSKX83.06-2.65
-3.09%
Fidelity Advisor Stock Sel All Cp K
BSGIX17.36-0.62
-3.45%
Baird Small/Mid Cap Growth Institutional
PMJIX11.47-0.43
-3.61%
PIMCO RAE US Small Instl

SVRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SVRA has been loosely correlated with LRMR. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if SVRA jumps, then LRMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SVRA
1D Price
Change %
SVRA100%
-6.21%
LRMR - SVRA
42%
Loosely correlated
-3.70%
XENE - SVRA
39%
Loosely correlated
-4.68%
PLRX - SVRA
38%
Loosely correlated
-2.57%
KYMR - SVRA
37%
Loosely correlated
-7.66%
IDYA - SVRA
37%
Loosely correlated
-2.81%
More